Literature DB >> 2712635

Percutaneous cardiopulmonary bypass for the treatment of hypothermic circulatory collapse.

G W Laub1, D Banaszak, J Kupferschmid, G J Magovern, J C Young.   

Abstract

Environmentally induced hypothermia has a very high mortality. Cardiopulmonary bypass affords the best chance of survival from hypothermia but can be time-consuming to institute. We have utilized percutaneous cardiopulmonary bypass with recently developed bypass catheters to resuscitate a patient with profound hypothermia complicated by circulatory collapse. Percutaneous cardiopulmonary bypass appears to be the treatment of choice for profound hypothermia.

Entities:  

Mesh:

Year:  1989        PMID: 2712635     DOI: 10.1016/0003-4975(89)90445-1

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  4 in total

Review 1.  Brain vulnerability and viability after ischaemia.

Authors:  Stefano G Daniele; Georg Trummer; Konstantin A Hossmann; Zvonimir Vrselja; Christoph Benk; Kevin T Gobeske; Domagoj Damjanovic; David Andrijevic; Jan-Steffen Pooth; David Dellal; Friedhelm Beyersdorf; Nenad Sestan
Journal:  Nat Rev Neurosci       Date:  2021-07-21       Impact factor: 34.870

2.  Rewarming From Hypothermic Cardiac Arrest Applying Extracorporeal Life Support: A Systematic Review and Meta-Analysis.

Authors:  Lars J Bjertnæs; Kristian Hindberg; Torvind O Næsheim; Evgeny V Suborov; Eirik Reierth; Mikhail Y Kirov; Konstantin M Lebedinskii; Torkjel Tveita
Journal:  Front Med (Lausanne)       Date:  2021-05-13

3.  Partial cardiopulmonary bypass for the treatment of profound accidental hypothermic circulatory collapse.

Authors:  P S Wong; W B Pugsley
Journal:  J R Soc Med       Date:  1992-10       Impact factor: 18.000

4.  Post-hypothermic cardiac left ventricular systolic dysfunction after rewarming in an intact pig model.

Authors:  Ole Magnus Filseth; Ole-Jakob How; Timofei Kondratiev; Tor Magne Gamst; Torkjel Tveita
Journal:  Crit Care       Date:  2010-11-23       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.